1. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R

Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et Biophysica acta-Reviews on Cancer 1826: 297-311, 2012. [Review] 

 doi: 10.1016/j.bbcan.2012.05.002 PMID: 22613680.

 

2. Paredes J, Correia AL, Ribeiro AS, Milanezi F, Cameselle-Teijeiro J, Schmitt FC

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localization and poor patient survival. Journal of clinical pathology 61: 856-62, 2008. [Article] 

 doi: 10.1136/jcp.2007.052704 PMID: 18381381.

 

3. Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC

P-cadherin expression in breast cancer: a review. Breast cancer research : BCR 9: 214, 2007. [Review] 

 doi: 10.1186/bcr1774 PMID: 18001487.

 

4. Paredes J, Lopes N, Milanezi F, Schmitt FC

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Archiv : an international journal of pathology 450: 73-80, 2007. [Article] 

 doi: 10.1007/s00428-006-0334-y PMID: 17123107.

 

5. Paredes J, Correia AL, Ribeiro AS, Schmitt F

Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines. Cellular oncology : the official journal of the International Society for Cellular Oncology 29: 467-76, 2007. [Article] 

 PMID: 18032823.

 

6. Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical cancer research : an official journal of the American Association for Cancer Research 11: 5869-77, 2005. [Article] 

 doi: 10.1158/1078-0432.CCR-05-0059 PMID: 16115928.

 

7. Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F

P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer research 64: 8309-17, 2004. [Article] 

 doi: 10.1158/0008-5472.CAN-04-0795 PMID: 15548699.

 

8. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Archiv : an international journal of pathology 440: 16-21, 2002. [Article] 

 PMID: 11942571.

 

9. Paredes J, Milanezi F, Reis-Filho JS, Leitão D, Athanazio D, Schmitt F

Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathology, research and practice 198: 795-801, 2002. [Article] 

 PMID: 12608656.

 

1. Ribeiro AS, Nobre AR, Mendes N, Almeida J, Vieira AF, Sousa B, Carvalho FA, Monteiro J, Polónia A, Fonseca M, Sanches JM, Santos NC, Seruca R, Paredes J

SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells. Cell communication and signaling : CCS 16: 75, 2018. [Article] 

 doi: 10.1186/s12964-018-0286-2 PMID: 30404626.

 

2. Polónia A, Pinto R, Cameselle-Teijeiro JF, Schmitt FC, Paredes J

Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer. Journal of clinical pathology 70: 860-867, 2017. [Article] 

 doi: 10.1136/jclinpath-2016-203990 PMID: 28373294.

 

3. Vieira AF, Dionísio MR, Gomes M, Cameselle-Teijeiro JF, Lacerda M, Amendoeira I, Schmitt F, Paredes J

P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 30: 698-709, 2017. [Article] 

 doi: 10.1038/modpathol.2016.232 PMID: 28084338.

 

4. Ribeiro AS, Carvalho FA, Figueiredo J, Carvalho R, Mestre T, Monteiro J, Guedes AF, Fonseca M, Sanches J, Seruca R, Santos NC, Paredes J

Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells. Nanoscale 8: 19390-19401, 2016. [Article] 

 doi: 10.1039/c6nr04465d PMID: 27847941.

 

5. Vieira AF, Paredes J

P-cadherin and the journey to cancer metastasis. Molecular cancer 14: 178, 2015. [Review] 

 doi: 10.1186/s12943-015-0448-4 PMID: 26438065.

 

6. Ribeiro AS, Paredes J

P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State. Frontiers in oncology 4: 371, 2014. [Article] 

 doi: 10.3389/fonc.2014.00371 PMID: 25601904.

 

7. Vieira AF, Ribeiro AS, Dionísio MR, Sousa B, Nobre AR, Albergaria A, Santiago-Gómez A, Mendes N, Gerhard R, Schmitt F, Clarke RB, Paredes J

P-cadherin signals through the laminin receptor a6ß4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget 5: 679-92, 2014. [Article] 

 PMID: 24553076.

 

8. Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC cancer 14: 734, 2014. [Article] 

 doi: 10.1186/1471-2407-14-734 PMID: 25269858.

 

9. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology 229: 705-18, 2013. [Article] 

 doi: 10.1002/path.4143 PMID: 23180380.

 

10. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J

P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem cells (Dayton, Ohio) 30: 854-64, 2012. [Article] 

 doi: 10.1002/stem.1075 PMID: 22389315.

 

11. Schmitt F, Ricardo S, Vieira AF, Dionísio MR, Paredes J

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Archiv : an international journal of pathology 460: 545-53, 2012. [Review] 

 doi: 10.1007/s00428-012-1237-8 PMID: 22562130.

 

12. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J

Claudin expression in breast cancer: High or low, what to expect? Histology and histopathology 27: 1283-95, 2012. [Article] 

 PMID: 22936447.

 

13. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Journal of clinical pathology 64: 937-46, 2011. [Article] 

 doi: 10.1136/jcp.2011.090456 PMID: 21680574.

 

14. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402, 2010. [Article] 

 doi: 10.1038/onc.2009.338 PMID: 19901964.